Jefferies Financial Group Inc. Uro Gen Pharma Ltd. Put Options Transaction History
Jefferies Financial Group Inc.
- $11 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding URGN
# of Institutions
148Shares Held
44MCall Options Held
146KPut Options Held
42.1K-
Rtw Investments, LP New York, NY4.54MShares$87.2 Million0.96% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$83.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$42.1 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY2.15MShares$41.3 Million1.7% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$33.6 Million0.04% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $437M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...